Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges with Dedicated Psychedelic Research Groups
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

P3A Study Group

Université Laval / CHU de Québec, Canada

The P3A project is a multidisciplinary research initiative in Quebec exploring the acceptability and accessibility of psilocybin-assisted therapy for palliative and end-of-life care, focusing on alleviating existential distress.

Academic Research

0 papers

Published Papers

0

Trial Involvement

0

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
academic
HQ
Université Laval / CHU de Québec, Canada
Website
Visit